Back to search

Article

Optimizing CRISPR/Cas9 genome editing in primary human hematopoietic cells to advance studies into HIV biology

2026-08-05

Abstract excerpt

Defining how human host factors shape HIV-1 infection in vivo remains essential for the development of genetically engineered cell therapies. Here, we established a non-viral CRISPR/Cas9 ribonucleoprotein-based platform for efficient single and multiplex gene editing in primary human CD34 + hematopoietic stem and progenitor cells (HSPCs). Edited HSPCs retained viability, proliferative capacity, primitive immunop...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1fa0235a-99ea-5bed-8307-bcac6a55c546
DOI
10.64898/2026.08.05.741689
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Optimizing CRISPR/Cas9 genome editing in primary human hematopoietic cells to advance studies into HIV biologyDOI 10.64898/2026.08.05.741689
Select a neighboring publication to make it the new centre.